Cara Therapeutics reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Aerie Pharmaceuticals AERI:US USD 312.59M 458K
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Horizon Pharma HZNP:US USD 2.55B 1.85M
JAZZ PHA JAZZ:US USD 5.7B 294.18M
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Revance Therapeutics RVNC:US USD 378.89M 506K
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B